Company: BIVIW
Filing Date: 2025-07-22
Form Type: S-1/A
Source: 0001520138-25-000216
Chunk: 116

Company: BIOVIE INC.
Filing Date: 2025-07-22
Form: S-1/A
Chunk 116
---
 Board of Directors are primarily based on her decades of experience in clinical neuroscience and drug development.

Mr. Kameel D. Farag has served as a director
of the Company since 2025. Most recently, he was Chief Financial Officer, Treasurer and head of business operations at Aspen Neuroscience
from 2021 to 2025, where he oversaw tripling the company’s headcount, secured over $150 million in financing, built manufacturing
infrastructure and prepared the company for clinical data and a potential future public offering. Prior to that, he served as Senior
Vice President, Finance at Ionis Pharmaceuticals from 2018 to 2021. In addition, Mr. Farag spent over 16 years at Amgen Inc. in a variety
of finance and operational roles including Chief Financial Officer of Amgen's Intercontinental Region from 2013 to 2018 and as its Head
of International FP&A and Interim International Chief Financial Officer from 2009 to 2013. Mr. Farag holds a BA from the University
of California, Santa Barbara.

Mr. Farag’s qualifications to serve on
our Board of Directors are primarily based on his experience as a biotech and global finance executive with a track record of scaling
companies through transformational growth.

Mr. Sigmund Rogich has served as a director
of the Company since 2020. He is the CEO and President of The Rogich Communications Group and serves on the Board of Keep Memory Alive,
a philanthropic organization which raises awareness about brain disorders and Alzheimer’s disease. Keep Memory Alive funds clinical
trials to advance new treatments for patients with Alzheimer’s, Huntington’s and Parkinson’s disease, as well as multiple
sclerosis. Mr. Rogich was formerly the U.S. Ambassador to Iceland. He has served as a senior consultant to Presidents Ronald Reagan and
George H.W. Bush. Mr. Rogich serves on multiple boards of directors for charitable causes.

Mr. Rogich’s qualifications to serve on
our Board of Directors are based on his experience in the Communications sector and philanthropic organization raising awareness about
brain disorders. His experience in service as a senior consultant to candidates of the highest office.

Mr. Michael Sherman has served as a director
of the Company since 2017. He retired from his position as a Managing Director at Barclays Plc in 2018, where he had worked since 2008.
Previously he was a Managing Director at Lehman Brothers, Inc. He has worked in